Press Releases May 15, 2026 08:00 AM

LifeMD to Participate in Upcoming Investor Conferences

LifeMD Announces Participation in Upcoming Key Investor Conferences

By Leila Farooq
Share
Twitter Reddit Facebook LinkedIn
LFMD

LifeMD, Inc., a leading virtual primary care platform, announced that its management will participate in the LD Micro Invitational XVI Conference and the B. Riley Securities 26th Annual Investor Conference in May 2026. The company aims to engage with investors through presentations and one-on-one meetings to discuss its telemedicine offerings and growth strategy.

LifeMD to Participate in Upcoming Investor Conferences
LFMD
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • LifeMD management will present at LD Micro Invitational XVI Conference on May 19, 2026, and hold meetings at B. Riley Securities 26th Annual Investor Conference on May 20, 2026.
  • LifeMD offers a comprehensive telemedicine platform covering over 200 conditions, combining virtual care, pharmacy, and lab services for greater accessibility.
  • The company is leveraging a vertically integrated digital care system and a nationwide affiliated medical group to provide affordable primary care services.

NEW YORK, May 15, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading platform for virtual primary care services, today announced that management will be participating in two upcoming investor conferences.

  • LD Micro Invitational XVI Conference, May 17 - 19, 2026 at the Luxe Sunset Boulevard Hotel in Los Angeles. Management will deliver a company presentation on Tuesday, May 19th at 9:00 a.m. Pacific time and will be available for one-on-one meetings. Investors can register for the conference here.
  • B. Riley Securities 26th Annual Investor Conference, May 20 - 21, 2026, in Marina del Rey, Calif. Management will be holding one-on-one meetings on Wednesday, May 20th. Investors can register for the conference and request a meeting by contacting their B. Riley Securities representative.

About LifeMD, Inc.

LifeMD® is a leading platform for virtual primary care. LifeMD offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across more than 200 conditions, including primary care, men’s and women’s health, weight management, and hormone therapy. The Company leverages a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a state-of-the-art affiliated pharmacy, and a U.S.-based patient care center to increase access to high-quality and affordable care. For more information, please visit LifeMD.com.

Investor Contact
investors@lifemd.com

Media Contact
press@lifemd.com


Risks

  • Market volatility around investor presentations can create uncertainty in stock price reactions despite positive company engagement.
  • Competition in the telemedicine and virtual healthcare sector remains intense, potentially impacting LifeMD's growth and market share.
  • Regulatory changes in healthcare, particularly telemedicine and pharmacy operations across 50 states, could affect company performance and operational costs.

More from Press Releases

Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma Jun 14, 2026 Phase 3 Data Show TransCon® PTH Replicated Systemic Actions of Endogenous PTH Through Week 182 in Adults with Hypoparathyroidism Jun 13, 2026 Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026